SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The largest domestic drug maker Ranbaxy Laboratories is planning to introduce two of Daiichi Sankyos discovered products in Mexico. Both have agreed to commercialise olmesartan medoxomil—an anti-hypertensive developed by Daiichi Sankyo—in Mexico. Ranbaxy had recently announced its plans to launch this anti-hypertensive drug in six African countries that include Kenya, Mozambique, Nigeria, Tanzania, Uganda, and Zambia.

 

Olmesartan medoxomil is already available in more than 50 countries worldwide. Additionally, the two companies plan to promote Prasugrel, an anti-platelet, co-developed by Daiichi Sankyo and Eli Lilly, in the Latin American market. Prasugrel will be co-promoted by Lilly's affiliate in Mexico.

 

With an estimated population of 107 million people, Mexico is Latin American region's second largest market after Brazil, with annual pharma sales of about $10.4 billion. After acquiring Ranbaxy in 2008 for $4.6 billion, Daiichi has been using the Indian pharma company's marketing muscle and distribution strength to create a presence and consolidate its position in emerging markets-mainly in Eastern Europe, Africa and Latin America.

crackcrack
Peers
Company Name CMP
Sun Pharma Inds. 1645.25
Dr. Reddys Lab 1215.30
Cipla 1213.45
Zydus Lifesciences 912.50
Lupin 2330.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×